Matches in Wikidata for { <http://www.wikidata.org/entity/Q92184280> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q92184280 description "article scientifique publié en 2019" @default.
- Q92184280 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92184280 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92184280 description "scientific article published on 20 December 2019" @default.
- Q92184280 description "wetenschappelijk artikel" @default.
- Q92184280 description "наукова стаття, опублікована 20 грудня 2019" @default.
- Q92184280 name "Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States" @default.
- Q92184280 name "Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States" @default.
- Q92184280 type Item @default.
- Q92184280 label "Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States" @default.
- Q92184280 label "Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States" @default.
- Q92184280 prefLabel "Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States" @default.
- Q92184280 prefLabel "Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States" @default.
- Q92184280 P1433 Q92184280-D251186B-E4E7-4D11-BFC2-C4D13D4FB59E @default.
- Q92184280 P1476 Q92184280-6B3B8EC3-4F0C-4627-908B-41F540ADD068 @default.
- Q92184280 P2093 Q92184280-3112D920-CBC4-4BB7-8DF9-CB5A0A6F7B5F @default.
- Q92184280 P2093 Q92184280-4BA7C5A0-A333-4B43-99D9-815D5CF061BF @default.
- Q92184280 P2093 Q92184280-6316D1B6-7E30-4687-92ED-6FC9D2C0E643 @default.
- Q92184280 P2093 Q92184280-79FB14CE-71DA-49AA-9C53-FB3AD0633381 @default.
- Q92184280 P2093 Q92184280-EEA70647-9382-4D38-95DC-91927559407E @default.
- Q92184280 P2093 Q92184280-FDA71D0F-0518-40E3-B8E3-4DB218F3A7FF @default.
- Q92184280 P304 Q92184280-3CB29F25-2733-4278-BD39-428190182FEF @default.
- Q92184280 P31 Q92184280-32A4AF76-3B53-4651-88B1-26EA8915E39D @default.
- Q92184280 P356 Q92184280-97C4CFF6-4435-4346-9DE6-92020492E6A3 @default.
- Q92184280 P433 Q92184280-0B0DA7F5-C297-4120-9D4C-21F9F0F2CEBF @default.
- Q92184280 P478 Q92184280-0670D21C-F1F0-4AF6-B4B8-6ED3E78BB48D @default.
- Q92184280 P577 Q92184280-67744C02-51D2-4656-94E1-F9EF49181435 @default.
- Q92184280 P698 Q92184280-C3B52D1F-E5C9-4881-B861-A7BDEE065C17 @default.
- Q92184280 P356 J.JAAD.2019.12.034 @default.
- Q92184280 P698 31866263 @default.
- Q92184280 P1433 Q15757046 @default.
- Q92184280 P1476 "Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States" @default.
- Q92184280 P2093 "Alyce M Anderson" @default.
- Q92184280 P2093 "Hasan Khosravi" @default.
- Q92184280 P2093 "Laura K Ferris" @default.
- Q92184280 P2093 "Sonal Choudhary" @default.
- Q92184280 P2093 "Sophia Zhang" @default.
- Q92184280 P2093 "Timothy Patton" @default.
- Q92184280 P304 "1023-1024" @default.
- Q92184280 P31 Q13442814 @default.
- Q92184280 P356 "10.1016/J.JAAD.2019.12.034" @default.
- Q92184280 P433 "4" @default.
- Q92184280 P478 "82" @default.
- Q92184280 P577 "2019-12-20T00:00:00Z" @default.
- Q92184280 P698 "31866263" @default.